Clinical Trial

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

Study acronym: ABATE
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA Office of Orphan Products Development (OOPD)
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2020-03-01; most recent amendment 2025-09-26.
Status change: Not Yet Recruiting → Recruiting 2021-02-11
Trial Details
NCT Number NCT04294043
Lead Sponsor Chris Goss
Collaborators: Cystic Fibrosis Foundation
Conditions Nontuberculous Mycobacterium Infection
Enrollment 40 participants
Start Date 2021-06-17
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-01